Penicillin and the Marked Decrease in Morbidity and Mortality from Rheumatic Fever in the United States

New England Journal of Medicine

Volumn 318, Issue 5, 1988, Pages 280-286

  Massell, Benedict F ^a   Chute, Christopher G ^a   Walker, Alexander M ^a   Kurland, George S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

HUMAN; MORBIDITY; MORTALITY; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; RHEUMATIC PANCARDITIS; STREPTOCOCCUS PYOGENES;

EID: 0023846067     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198802043180504     Document Type: Article

References (39)

1. Stollerman GH, Siegel Achéal, Johnson EE. Variable epidemiology of streptococcal disease and the changing pattern of rheumatic fever. Mod Concepts Cardiovasc Dis 1965; 34: 45–8.
2. Land MA, Bisno AL. Acute rheumatic fever: a vanishing disease in suburbia. JAMA 1983; 249: 895–8.
3. Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger, 1984.
4. Markowitz M. The decline of rheumatic fever: role of medical intervention. J Pediatr 1985; 106: 545–50.
5. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. Circulation 1985; 72: 1155–62.
6. Hedley OF. Trends, geographical and racial distribution of mortality from heart disease among persons 5–24 years of age in the United States during recent years (1922–1936): a preliminary report. Public Health Rep 1939; 54: 2271–97.
7. Bureau of the Census. Mortality statistics of the United States 1921–1936. Washington, D.C.: Government Printing Office, 1924–1938.
8. Bureau of the Census. Vital statistics of the United States 1937–1944. Washington, D.C.: Government Printing Office, 1939–1946.
9. Public Health Service. Vital statistics of the United States 1945–1978. Washington, D.C.: Government Printing Office, 1947–1982.
10. Bureau of the Census. Estimates of the population of the United States, by single years of age, color, and sex: 1900 to 1959. In: Current population reports: population estimates. Series P-25, No. 311, July 2, 1965. Washington, D.C.: Government Printing Office, 1965.
11. Linder FE, Grove RD. Vital statistics rates in the United States 1900–1940. Washington, D.C.: Government Printing Office, 1943:1008.
12. Public Health Service. Vital statistics of the United States 1950. Vol. 1. Analysis and summary tables with supplemental tables for Alaska, Puerto Rico, and Virgin Islands. Washington, D.C.: Government Printing Office, 1954:56–7.
13. Public Health Service. Vital statistics of the United States 1966. Vol. 2. Mortality. Part A. Washington, D.C.: Government Printing Office, 1968:6–17.
14. Public Health Service. Vital statistics of the United States 1960–1978. Washington, D.C.: Government Printing Office, 1963–1982:Technical Appendices.
15. Berry G. The analysis of mortality by the subject-years method. Biometrics 1983; 39: 173–84.
16. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123: 174–84.
17. Goerner JR, Massell BF, Jones TD. Use of penicillin in the treatment of carriers of beta-hemolytic streptococci among patients with rheumatic fever. N Engl J Med 1947; 237: 576–80.
18. Massell BF, Dow JW, Jones TD. Orally administered penicillin in patients with rheumatic fever. JAMA 1948; 138: 1030–6.
19. Tompkins DG, Boxcrbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathinc penicillin. Circulation 1972; 45: 543–51.
20. Czoniczer G, Lees M, Massell BF. Streptococcal infection: the need for improved recognition and treatment for the prevention of rheumatic fever. N Engl J Med 1961; 265: 951–2.
21. Mortimer EA, Houser HB. The disappearance of rheumatic fever: Why? In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger, 1984:273–7.
22. Coburn AF, Young DC. The epidemiology of hemolytic streptococcus during World War II in the United States Navy. Baltimore: Williams & Wilkins, 1949:170–80.
23. Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89: 307–13.
24. Visseren F, Belani K, Johnson D, Kaplan E, Quie P. The role of capsule in phagocytosis of strains of Group A streptococci associated with the 1986 rheumatic fever outbreak. Presented at the National Meeting of the Lancefield Society, New York, October 7, 1987. abstract.
25. Rothbard S. Watson RF. Variation occurring in group A streptococci during human infection: progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med 1948; 87: 521–33.
26. Michael JG, Massell BF, Perkins RE. Effect of sublethal concentrations of penicillin on the virulence and antigenic composition of group A streptococci. J Bacteriol 1963; 85: 1280–7.
27. Poynton FJ, Paine A. Researches on rheumatism. London: J & A Churchill, 1913:394–5.
28. Glover JA. Incidence of rheumatic diseases. I. The incidence of acute rheumatism. Lancet 1930; 1: 499–505.
29. Paul JR. The epidemiology of rheumatic fever. 3rd ed. New York: American Heart Association, 1957:108–24.
30. Baumol WJ. America's productivity “crisis.” New York Times. February 15, 1987:Section 3:2.
31. Quinn RW. Epidemiology of group A streptococcal infections — their changing frequency and severity. Yale J Biol Med 1982; 55: 265–70.
32. Stollerman GH. Nephritogenic and rheumatogenic Group A streptococci. J Infect Dis 1969; 120: 258–63.
33. Bisno AL. The concept of rheumatogenic and nonrheumatogenic group A streptococci. In: Read SE, Zabriskie JB, eds. Streptococcal diseases and the immune response. New York: Academic Press, 1980:789–803.
34. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316: 421–7.
35. Hosier DM, Craenen JM, Teske DW, Wheller JJ. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141: 730–3.
36. Wald ER, Dashefsky B. Feidt C, Chiponis D, Byers C. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 1987; 80: 371–4.
37. Rizzo C, Congeni J, Congeni B, Kaplan E. Factors associated with the resurgence of rheumatic fever in Ohio. In: Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4–7, 1987. Washington, D.C.: American Society of Microbiology, 1987:114. abstract.
38. Marcon MJ, Hribar MM, Hosier DM, et al. Appearance and antimicrobial susceptibility of mucoidal Group A streptococci in a central Ohio pediatric population. In: Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4–7, 1987. Washington, D.C.: American Society of Microbiology, 1987:227. abstract.
39. GLIM Working Party. The generalized linear interactive modeling system. Release 3.77. Oxford: Algorithms Group, 1984.